{"transactions":[{"id":1921675,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92115,"kind":"person","name":"RIESCHEL GARY E","position":4,"cik":"0001248153","reported_name":"RIESCHEL GARY E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Voting Common Stock","published_at":"2023-04-11T19:55:00.000Z","date":"2023-01-27","kind":"purchase","planned":false,"acquired":true,"shares":2666666,"price":1.5,"value":3999999.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. Each of Qiming GP and Messrs. Rieschel and McDade disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein."}],"balance_after":8519648,"source":{"system":"sec-edgar","filing":"0001209191-23-024058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248153/000120919123024058/doc4.xml","form_type":"4"}},{"id":2619834,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":1275817,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":307004},"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2619833,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":12480498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3003224},"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2619832,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":13333,"price":15,"value":199995.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares reported herein as purchased on August 2, 2021 represent 13,333 shares of Common Stock purchased by Gary Rieschel."}],"balance_after":3523561,"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2619831,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":8018,"price":15,"value":120270.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares reported herein as purchased on August 2, 2021 represent 8,018 shares of Common Stock purchased by Mark McDade."}],"balance_after":3518246,"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2619830,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":200000,"price":15,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Shares reported herein as purchased on August 2, 2021 represent 200,000 shares of Common Stock purchased by Qiming."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming."}],"balance_after":3510228,"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2619829,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":73857,"kind":"person","name":"MCDADE MARK","position":3,"cik":"0001242126","reported_name":"MCDADE MARK","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-08-02T21:27:12.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":3310228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming."}],"balance_after":3310228,"source":{"system":"sec-edgar","filing":"0000899243-21-031149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242126/000089924321031149/doc4.xml","form_type":"4"}},{"id":2647067,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-07-01T19:45:43.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":1694730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":401065},"source":{"system":"sec-edgar","filing":"0001209191-21-044606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1765710/000120919121044606/doc4.xml","form_type":"4"}},{"id":2647066,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-07-01T19:45:43.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":7000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1656577},"source":{"system":"sec-edgar","filing":"0001209191-21-044606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1765710/000120919121044606/doc4.xml","form_type":"4"}},{"id":2647065,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T19:45:43.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming."}],"balance_after":2370142,"source":{"system":"sec-edgar","filing":"0001209191-21-044606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1765710/000120919121044606/doc4.xml","form_type":"4"}},{"id":2647064,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T19:45:43.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":401065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming."}],"balance_after":2057642,"source":{"system":"sec-edgar","filing":"0001209191-21-044606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1765710/000120919121044606/doc4.xml","form_type":"4"}},{"id":2647063,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":114538,"kind":"organization","name":"Qiming U.S. Healthcare Fund II, L.P.","position":1,"cik":"0001765710","reported_name":"Qiming U.S. Healthcare Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114539,"kind":"organization","name":"Qiming U.S. Healthcare GP II, LLC","position":2,"cik":"0001868862","reported_name":"Qiming U.S. Healthcare GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T19:45:43.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":1656577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. (\"Qiming\"). Qiming U.S. Healthcare GP II, LLC (\"Qiming GP\") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming."}],"balance_after":1656577,"source":{"system":"sec-edgar","filing":"0001209191-21-044606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1765710/000120919121044606/doc4.xml","form_type":"4"}}]}